Class II · Moderate risk
potassium phosphate 15 mmole added to 0.9% sodium Chloride 250 mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II drug recalls - moderate risk
Class II means the product may cause temporary or medically reversible harm, and serious harm is unlikely. It is by far the largest recall class - most potency, dissolution and labeling problems land here.
14,535 recalls, newest first.
Class II · Moderate risk
norepinephrine
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
NORepinephrine 4 mg/250 mL added to 0.9% sodium chloride 16 mcg/mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
oxyTOCIN 30 units added to 0.9% sodium chloride 500 mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
oxyTOCIN 20 units added to Lactated Ringer's 1000 mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
oxyTOCIN
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
neostigmine 5 mg/5mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
heparin 7500 units added to 0.9% sodium chloride 1000mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
Neonatal TPN Starter Bag
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
heparin 5000 units/500mL added to 0.9% sodium chloride
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
heparin 4000 units/1000mL added to 0.9% sodium chloride
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
heparin 2500 units/500mL added to 0.9% sodium chloride 5 units/mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
oxyTOCIN 20 units added to 0.9% sodium chloride 1
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
oxyTOCIN 15 units added to Lactated Ringer's 250 mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
heparin 2500 units added to 0.9% sodium chloride 250mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
oxyTOCIN 15 units added to 0.9% sodium chloride 250 mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
oxyTOCIN 10 units added to Lactated Ringer's 500 mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
vancomycin 750 mg/250 mL added to 0.9% Sodium Chloride
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
vancomycin 2 g/500 mL added to 0.9% Sodium Chloride
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
vancomycin 1.75g added to 0.9% sodium chloride 500mL
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
vancomycin 1.5 g/250mL added to 5% dextrose
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
vancomycin 1.5 g/500 mL added to 0.9% sodium chloride
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
vancomycin 1.5 g/250 mL added to 0.9% sodium chloride
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
Class II · Moderate risk
PHENYLephrine 1
Lack of assurance of sterility. Validation data for decontamination cycles is lacking.